Financial Snapshot

Revenue
$10.64K
TTM
Gross Margin
-484.25%
TTM
Net Earnings
-$7.254M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
3.52%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$5.085M
Q3 2024
Cash
Q3 2024
P/E
-0.2905
Nov 29, 2024 EST
Free Cash Flow
-$955.6K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $7.589K $125.7K $38.26K $59.57K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -93.96% 228.44% -35.77%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $7.589K $125.7K $38.26K $59.57K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost Of Revenue $173.1K $300.8K $19.74K $104.7K
Gross Profit -$165.5K -$175.1K $18.52K -$45.16K
Gross Profit Margin -2181.22% -139.34% 48.41% -75.81%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Selling, General & Admin $1.881M $2.019M $3.210M $7.839M $5.719M $26.96K $56.88K $36.66K $26.50K $420.00
YoY Change -6.82% -37.1% -59.06% 37.08% 21111.13% -52.6% 55.16% 38.34% 6209.52%
% of Gross Profit 17329.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $34.27K $42.29K $40.32K $33.61K $19.67K
YoY Change -18.97% 4.88% 19.96% 70.87%
% of Gross Profit 217.71%
Operating Expenses $1.915M $2.061M $3.250M $7.872M $5.719M $26.96K $56.88K $21.89K $26.50K $420.00
YoY Change -7.07% -36.58% -58.72% 37.67% 21111.13% -52.6% 159.84% -17.4% 6209.52%
Operating Profit -$2.081M -$2.236M -$3.231M -$7.918M
YoY Change -6.94% -30.8% -59.19%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Interest Expense $308.7K $956.9K -$508.8K -$47.59K -$382.6K
YoY Change -67.73% -288.07% 969.07% -87.56%
% of Operating Profit
Other Income/Expense, Net -$1.872M -$823.3K $27.00K $14.77K
YoY Change 127.42% -3149.41%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Pretax Income -$3.953M -$3.059M -$3.785M -$7.965M -$6.207M -$26.96K -$56.88K -$21.89K -$26.50K -$420.00
YoY Change 29.22% -19.16% -52.49% 28.32% 22923.66% -52.6% 159.84% -17.4% 6209.52%
Income Tax $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$3.953M -$3.059M -$3.785M -$7.965M -$6.207M -$26.96K -$56.88K -$21.89K -$26.50K -$420.00
YoY Change 29.22% -19.16% -52.49% 28.32% 22923.66% -52.6% 159.84% -17.4% 6209.52%
Net Earnings / Revenue -52092.78% -2434.69% -9891.69% -13371.09%
Basic Earnings Per Share -$0.05 -$0.05 -$0.06
Diluted Earnings Per Share -$0.05 -$0.05 -$62.45K -$163.1K -$151.1K -$20.39K -$43.01K -$16.55K -$25.02K -$396.50

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash & Short-Term Investments $730.00 $11.02K $119.7K $28.92K $282.4K $0.00 $0.00 $0.00 $5.700K $1.000K
YoY Change -93.38% -90.79% 313.83% -89.76% -100.0% 470.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $13.16K $45.95K $48.84K $19.23K $132.3K $700.00 $600.00 $0.00
YoY Change -71.36% -5.92% 153.98% -85.47% 18805.71%
Inventory $0.00 $54.15K $198.6K $267.2K $24.68K
Prepaid Expenses
Receivables $0.00 $12.36K $19.88K $5.640K
Other Receivables $0.00 $0.00 $257.2K $99.68K
Total Short-Term Assets $13.88K $123.5K $644.2K $420.6K $574.2K $700.00 $0.00 $0.00 $6.300K $1.300K
YoY Change -88.76% -80.83% 53.15% -26.74% 81924.29% -100.0% 384.62%
Property, Plant & Equipment $0.00 $1.415M $1.003M $921.9K $1.201M
YoY Change -100.0% 41.03% 8.8% -23.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $85.00K $1.450M $1.256M $65.11K $72.53K
YoY Change -94.14% 15.43% 1829.03% -10.23%
Total Long-Term Assets $85.00K $3.044M $2.259M $987.0K $1.273M $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -97.21% 34.76% 128.88% -22.48%
Total Assets $98.88K $3.168M $2.903M $1.408M $1.847M $700.00 $0.00 $0.00 $6.300K $1.300K
YoY Change
Accounts Payable $528.7K $798.1K $480.2K $734.6K $330.5K $420.00 $87.92K $30.57K $0.00
YoY Change -33.76% 66.21% -34.63% 122.24% 78595.24% -99.52% 187.6%
Accrued Expenses $1.689M $1.035M $457.8K $595.8K $164.8K $0.00 $0.00
YoY Change 63.27% 126.03% -23.17% 261.6%
Deferred Revenue
YoY Change
Short-Term Debt $1.457M $995.0K $456.6K $334.8K $637.3K $0.00 $0.00 $0.00 $3.420K $1.720K
YoY Change 46.47% 117.92% 36.36% -47.46% -100.0% 98.84%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.872M $2.977M $1.524M $1.702M $1.133M $420.00 $98.35K $41.47K $3.420K $1.720K
YoY Change 30.05% 95.42% -10.51% 50.31% 269571.43% -99.57% 137.16% 1112.57% 98.84%
Long-Term Debt $0.00 $900.0K $200.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 350.0%
Other Long-Term Liabilities $0.00 $341.7K $0.00 $156.3K $453.3K
YoY Change -100.0% -100.0% -65.53%
Total Long-Term Liabilities $0.00 $1.242M $200.0K $156.3K $453.3K $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% 520.84% 28.0% -65.53%
Total Liabilities $3.872M $4.219M $1.724M $1.859M $1.586M $420.00 $98.35K $41.47K $3.420K $1.720K
YoY Change -8.22% 144.79% -7.27% 17.2% 377488.1% -99.57% 137.16% 1112.57% 98.84%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Basic Shares Outstanding 73.33M shares 66.19M shares 60.60M shares
Diluted Shares Outstanding 73.33M shares 66.19M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $2.1072 Million

About One World Products, Inc.

One World Products, Inc. engages in the production and manufacturing of raw cannabis and hemp plant ingredients for both medical and industrial uses. The company is headquartered in Las Vegas, Nevada and currently employs 10 full-time employees. The company went IPO on 2015-09-25. OWP SAS has the licenses to cultivate, produce and distribute the raw ingredients of the cannabis and hemp plant for medicinal, scientific, and industrial purposes in the town of Esmeralda-Popayan, Cauca, Colombia. Its business involves the cultivating, processing, and supplying crude cannabis oil, distillate and isolate to customer specifications. OWP SAS owns approximately 30 acres and has a covered greenhouse built specifically to cultivate high-grade cannabis and hemp. In addition, it has entered into agreements with local farming co-operatives that include small farmers and indigenous tribe members, under, which they cultivate cannabis on up to approximately 140 acres of land using the Company seeds and propagation techniques and sell their harvested products to the Company on an exclusive basis.

Industry: Pharmaceutical Preparations Peers: Enveric Biosciences, Inc. AmeriCann, Inc. Can B Corp Evoke Pharma Inc KIORA PHARMACEUTICALS INC Grapefruit USA, Inc GREEN HYGIENICS HOLDINGS INC. JOHNSON & JOHNSON NovaBay Pharmaceuticals, Inc. Sonoma Pharmaceuticals, Inc.